title: Complete response of acquired FV inhibitor to rituximab.
authors.affiliation: Department of Pathology, Hong Kong Sanatorium and Hospital, 1/F Li Shu Fan Block, 2 Village Road, Happy Valley, Hong Kong, China, eskma@hksh.com.
authors.forename: Edmond S K
authors.initials: ES
authors.lastname: Ma
authors.forename: Raymond H S
authors.initials: RH
authors.lastname: Liang
authors.forename: Kent-Man
authors.initials: KM
authors.lastname: Chu
authors.forename: George K K
authors.initials: GK
authors.lastname: Lau
mesh_terms: D000369:Aged, 80 and over; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D001778:Blood Coagulation Disorders / Q000209:etiology / Q000628:therapy*; D016913:Blood Component Transfusion; D005165:Factor V / Q000037:antagonists & inhibitors*; D005743:Gastrectomy; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D019106:Postoperative Hemorrhage / Q000209:etiology / Q000628:therapy*; D012074:Remission Induction; D000069283:Rituximab; D013274:Stomach Neoplasms / Q000601:surgery
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab; D005165:Factor V